Effects	NNS	effect NNS PennPOS
of	IN	of pp-f NUPOS
thymosin	NN	thymosin NN PennPOS
b4	NN	b4 NN PennPOS
and	CC	and cc NUPOS
its	PRP$	its po31 NUPOS
N-terminal	JJ	N-terminal JJ PennPOS
fragment	NN	fragment NN PennPOS
Ac-SDKP	NN	Ac-SDKP NN PennPOS
on	IN	on IN PennPOS
TGF-b-treated	JJ	tgf-b-treated JJ PennPOS
human	JJ	human JJ PennPOS
lung	NN	lung NN PennPOS
fibroblasts	NNS	fibroblast NNS PennPOS
and	CC	and cc NUPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
mouse	NN	mouse NN PennPOS
model	NN	model NN PennPOS
of	IN	of pp-f NUPOS
bleomycin-induced	JJ	bleomycin-induced JJ PennPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

UNASSIGNED	NNP	UNASSIGNED NNP PennPOS
:	:	: : NUPOS
Thymosin-b4	NN	Thymosin-b4 NN PennPOS
(	(	( ( NUPOS
Tb4	NN	Tb4 NN PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
its	PRP$	its po31 NUPOS
amino-terminal	JJ	amino-terminal JJ PennPOS
fragment	NN	fragment NN PennPOS
comprising	VBG	comprise VBG PennPOS
N-acetyl-seryl-aspartyl-lysyl-proline	NN	N-acetyl-seryl-aspartyl-lysyl-proline NN PennPOS
(	(	( ( NUPOS
Ac-SDKP	NN	Ac-SDKP NN PennPOS
)	)	) ) NUPOS
have	VBP	have vhb NUPOS
been	VBN	be vbn NUPOS
reported	VBN	report VBN PennPOS
to	TO	to p-acp NUPOS
act	VB	act VBP PennPOS
as	IN	as c-acp NUPOS
anti-inflammatory	JJ	anti-inflammatory JJ PennPOS
and	CC	and cc NUPOS
anti-fibrotic	JJ	anti-fibrotic JJ PennPOS
agents	NNS	agent NNS PennPOS
in	FW	in fw-la NUPOS
vitro	FW	vitro FW PennPOS
and	CC	and cc NUPOS
in	FW	in fw-la NUPOS
vivo	FW	vivo fw-la NUPOS
.	.	. . NUPOS

In	IN	in IN PennPOS
recent	JJ	recent JJ PennPOS
papers	NNS	paper NNS PennPOS
,	,	, , NUPOS
we	PRP	we pns12 NUPOS
have	VBP	have vhb NUPOS
shown	VBN	show VBN PennPOS
that	IN	that cst NUPOS
Tb4	NN	Tb4 NN PennPOS
exerts	VBZ	exert VBZ PennPOS
a	DT	a dt NUPOS
widely	RB	wide av-j NUPOS
protective	JJ	protective JJ PennPOS
role	NN	role NN PennPOS
in	IN	in IN PennPOS
mice	NNS	mouse n2 NUPOS
treated	VBN	treat VBN PennPOS
with	IN	with pp NUPOS
bleomycin	NN	bleomycin NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
in	IN	in IN PennPOS
particular	JJ	particular JJ PennPOS
,	,	, , NUPOS
we	PRP	we pns12 NUPOS
have	VBP	have vhb NUPOS
demonstrated	VBN	demonstrate VBN PennPOS
its	PRP$	its po31 NUPOS
inhibitory	JJ	inhibitory JJ PennPOS
effects	NNS	effect NNS PennPOS
on	IN	on IN PennPOS
both	DT	both d NUPOS
inflammation	NN	inflammation NN PennPOS
and	CC	and cc NUPOS
early	JJ	early JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

OBJECTIVES	NNS	objective NNS PennPOS
:	:	: : NUPOS
In	IN	in IN PennPOS
this	DT	this d NUPOS
study	NN	study NN PennPOS
,	,	, , NUPOS
the	DT	the dt NUPOS
putative	JJ	putative JJ PennPOS
anti-proliferative	JJ	anti-proliferative JJ PennPOS
and	CC	and cc NUPOS
anti-fibrogenic	JJ	anti-fibrogenic JJ PennPOS
effects	NNS	effect NNS PennPOS
of	IN	of pp-f NUPOS
Tb4	NN	Tb4 NN PennPOS
and	CC	and cc NUPOS
Ac-SDKP	NN	Ac-SDKP NN PennPOS
were	VBD	be vbd NUPOS
evaluated	VBN	evaluate VBN PennPOS
in	FW	in fw-la NUPOS
vitro	FW	vitro FW PennPOS
.	.	. . NUPOS

In	IN	in IN PennPOS
addition	NN	addition NN PennPOS
,	,	, , NUPOS
the	DT	the dt NUPOS
effects	NNS	effect NNS PennPOS
of	IN	of pp-f NUPOS
Tb4	NN	Tb4 NN PennPOS
up	IN	up IN PennPOS
to	TO	to p-acp NUPOS
21	CD	21 crd NUPOS
days	NNS	day n2 NUPOS
were	VBD	be vbd NUPOS
evaluated	VBN	evaluate VBN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
bleomycin	NN	bleomycin NN PennPOS
mouse	NN	mouse NN PennPOS
model	NN	model NN PennPOS
of	IN	of pp-f NUPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

METHODS	NNS	method NNS PennPOS
:	:	: : NUPOS
We	PRP	we pns12 NUPOS
utilized	VBD	utilize VBD PennPOS
both	CC	both CC PennPOS
control	NN	control NN PennPOS
and	CC	and cc NUPOS
TGF-b-stimulated	JJ	tgf-b-stimulated JJ PennPOS
primary	JJ	primary JJ PennPOS
human	JJ	human JJ PennPOS
lung	NN	lung NN PennPOS
fibroblasts	NNS	fibroblast NNS PennPOS
isolated	VBN	isolate VBN PennPOS
from	IN	from pp NUPOS
both	DT	both d NUPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
control	JJ	control JJ PennPOS
tissues	NNS	tissue NNS PennPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
in	FW	in fw-la NUPOS
vivo	FW	vivo fw-la NUPOS
effects	NNS	effect NNS PennPOS
of	IN	of pp-f NUPOS
Tb4	NN	Tb4 NN PennPOS
were	VBD	be vbd NUPOS
assessed	VBN	assess VBN PennPOS
in	IN	in IN PennPOS
CD1	NN	cd1 NN PennPOS
mice	NNS	mouse n2 NUPOS
treated	VBN	treat VBN PennPOS
with	IN	with pp NUPOS
bleomycin	NN	bleomycin NN PennPOS
.	.	. . NUPOS

RESULTS	NNS	result NNS PennPOS
:	:	: : NUPOS
In	IN	in IN PennPOS
the	DT	the dt NUPOS
in	FW	in fw-la NUPOS
vitro	FW	vitro FW PennPOS
experiments	NNS	experiment NNS PennPOS
,	,	, , NUPOS
we	PRP	we pns12 NUPOS
observed	VBD	observe VBD PennPOS
significant	JJ	significant JJ PennPOS
anti-proliferative	JJ	anti-proliferative JJ PennPOS
effects	NNS	effect NNS PennPOS
of	IN	of pp-f NUPOS
Ac-SDKP	NN	Ac-SDKP NN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
fibroblasts	NNS	fibroblast NNS PennPOS
.	.	. . NUPOS

In	IN	in IN PennPOS
those	DT	those d NUPOS
cells	NNS	cell NNS PennPOS
,	,	, , NUPOS
Ac-SDKP	NN	Ac-SDKP NN PennPOS
significantly	RB	significant av-j NUPOS
inhibited	VBD	inhibit VBD PennPOS
TGF-b-induced	JJ	tgf-b-induced JJ PennPOS
a-SMA	NN	a-SMA NN PennPOS
and	CC	and cc NUPOS
collagen	NN	collagen NN PennPOS
expression	NN	expression NN PennPOS
,	,	, , NUPOS
hallmarks	NNS	hallmark NNS PennPOS
of	IN	of pp-f NUPOS
fibroblast	NN	fibroblast NN PennPOS
differentiation	NN	differentiation NN PennPOS
into	IN	into pp NUPOS
myofibroblasts	NNS	myofibroblast NNS PennPOS
triggered	VBN	trigger VBN PennPOS
by	IN	by IN PennPOS
TGF-b	NN	TGF-b NN PennPOS
.	.	. . NUPOS

In	FW	in fw-la NUPOS
vivo	FW	vivo fw-la NUPOS
,	,	, , NUPOS
despite	IN	despite pp NUPOS
its	PRP$	its po31 NUPOS
previously	RB	previous av-j NUPOS
described	VBN	describe VBN PennPOS
protective	JJ	protective JJ PennPOS
role	NN	role NN PennPOS
in	IN	in IN PennPOS
mice	NNS	mouse n2 NUPOS
treated	VBN	treat VBN PennPOS
with	IN	with pp NUPOS
bleomycin	NN	bleomycin NN PennPOS
at	IN	at pp NUPOS
7	CD	7 crd NUPOS
days	NNS	day n2 NUPOS
,	,	, , NUPOS
Tb4	NN	Tb4 NN PennPOS
failed	VBD	fail VBD PennPOS
to	TO	to p-acp NUPOS
prevent	VB	prevent VBP PennPOS
fibrosis	NN	fibrosis NN PennPOS
induced	VBN	induce VBN PennPOS
by	IN	by IN PennPOS
the	DT	the dt NUPOS
drug	NN	drug NN PennPOS
at	IN	at pp NUPOS
14	CD	14 crd NUPOS
and	CC	and cc NUPOS
21	CD	21 crd NUPOS
days	NNS	day n2 NUPOS
.	.	. . NUPOS

CONCLUSION	NN	conclusion NN PennPOS
:	:	: : NUPOS
We	PRP	we pns12 NUPOS
conclude	VBP	conclude VBP PennPOS
that	IN	that cst NUPOS
,	,	, , NUPOS
compared	VBN	compare VBN PennPOS
to	TO	to p-acp NUPOS
Tb4	NN	Tb4 NN PennPOS
,	,	, , NUPOS
Ac-SDKP	NN	Ac-SDKP NN PennPOS
may	MD	may vmb NUPOS
have	VB	have vhi NUPOS
greater	JJR	great JJR PennPOS
potential	NN	potential NN PennPOS
as	IN	as c-acp NUPOS
an	DT	a dt NUPOS
anti-fibrotic	JJ	anti-fibrotic JJ PennPOS
agent	NN	agent NN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
lung	NN	lung NN PennPOS
.	.	. . NUPOS

Further	RB	further av-jc NUPOS
in	FW	in fw-la NUPOS
vivo	FW	vivo fw-la NUPOS
experiments	NNS	experiment NNS PennPOS
are	VBP	be vbb NUPOS
warranted	VBN	warrant VBN PennPOS
.	.	. . NUPOS

